Correlation Between Rain Enhancement and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Rain Enhancement and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rain Enhancement and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rain Enhancement Technologies and InMed Pharmaceuticals, you can compare the effects of market volatilities on Rain Enhancement and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rain Enhancement with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rain Enhancement and InMed Pharmaceuticals.
Diversification Opportunities for Rain Enhancement and InMed Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Rain and InMed is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Rain Enhancement Technologies and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Rain Enhancement is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rain Enhancement Technologies are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Rain Enhancement i.e., Rain Enhancement and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Rain Enhancement and InMed Pharmaceuticals
Given the investment horizon of 90 days Rain Enhancement Technologies is expected to under-perform the InMed Pharmaceuticals. In addition to that, Rain Enhancement is 2.44 times more volatile than InMed Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.16 per unit of volatility. If you would invest 459.00 in InMed Pharmaceuticals on December 26, 2024 and sell it today you would lose (184.00) from holding InMed Pharmaceuticals or give up 40.09% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.0% |
Values | Daily Returns |
Rain Enhancement Technologies vs. InMed Pharmaceuticals
Performance |
Timeline |
Rain Enhancement Tec |
InMed Pharmaceuticals |
Rain Enhancement and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rain Enhancement and InMed Pharmaceuticals
The main advantage of trading using opposite Rain Enhancement and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rain Enhancement position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.Rain Enhancement vs. Ocean Biomedical | Rain Enhancement vs. Enveric Biosciences | Rain Enhancement vs. Elevation Oncology | Rain Enhancement vs. Hepion Pharmaceuticals |
InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |